Glycosphingolipid reduction with miglustat as a therapeutic strategy for CLN3 and other neuronal ceroid lipofuscinoses.

Lloyd-Evans, Emyr ORCID: https://orcid.org/0000-0002-3626-1611, Best, Hannah L., Alshehri, Abdullah S., Honeybun, Llinos and Waller-Evans, Helen ORCID: https://orcid.org/0000-0003-4133-6064 2023. Glycosphingolipid reduction with miglustat as a therapeutic strategy for CLN3 and other neuronal ceroid lipofuscinoses. Presented at: 19th Annual WORLDSymposium™ 2023, Orlando, Florida, 21-26 February 2023. Molecular Genetics and Metabolism. , vol.138 (2) Elsevier, p. 84. 10.1016/j.ymgme.2022.107212

Full text not available from this repository.

Item Type:	Conference or Workshop Item (Paper)
Date Type:	Published Online
Status:	Published
Schools:	Biosciences
Publisher:	Elsevier
ISSN:	1096-7192
Last Modified:	29 Jun 2024 11:11
URI:	https://orca.cardiff.ac.uk/id/eprint/158333

Actions (repository staff only)

Edit Item